{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:19:44Z","timestamp":1784636384284,"version":"3.55.0"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Blood donors are, in principle, healthy individuals who may be revealed as infectious for blood\u2010borne agents by the laboratory screening process, depicting the asymptomatic burden of the disease. Therefore, monitoring hepatitis C virus (<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>)\u2010infected donor and human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>)\u2010infected donor and associating to their demographical and behavioural characteristics may shed light on the dynamics and contemporary changes in these viruses' epidemiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Donors presenting repeatedly reactive <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> serology\/nucleic acid testing (<jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content>) screening results were submitted to confirmatory testing. Confirmed positive donors were invited to return to the blood bank for notification and counselling when a follow\u2010up sample was obtained and an interview performed to eventually disclose potential risks. <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010 or <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected donors identified over 11 years of screening (2004\u20132015) were evaluated for demographic and behavioural parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the period, 139 160 donations were screened, and 36 (0.025%) were found positive for <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>, stemming from 29 male and 7 female donors. Among those, eight subjects were repeat donors. A total of 95 donations were found repeatedly reactive for <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> (0.068%), obtained from 60 men and 35 women. Noticeably, in despite of a higher <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> prevalence in the donor population, the incidence of <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> among repeat donors was 10 times that of <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> (18 \u00d7 1.6\/100 000 persons\u2010year, respectively). On average, <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010seroreactive men were found to be younger (mean = 34 years old) than women (mean = 40 years old). A total of 10 donors acknowledged sexual behaviours not previously informed, including 2 who were aware of their <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive status and another 2 who admitted to be seeking <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> testing. No window period donation was verified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The majority of the <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected donors are young males who deny risk factors in the interview and also ignore the confidence self\u2010exclusion opportunity. As they may reiterate this behaviour in serial donations, use of the most sensitive laboratory testing is justified in this setting.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tme.12427","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T10:49:47Z","timestamp":1495190987000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Contrasting <scp>HCV<\/scp> and <scp>HIV<\/scp> seroepidemiology in 11 years of blood donors screening in Brazil"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3557-2717","authenticated-orcid":false,"given":"J. E.","family":"Levi","sequence":"first","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Lira","sequence":"additional","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. B.","family":"Bub","sequence":"additional","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Polite","sequence":"additional","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Terzian","sequence":"additional","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Kutner","sequence":"additional","affiliation":[{"name":"Hemotherapy and Cell Therapy Department Hospital Israelita Albert Einstein  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03840.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12299"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12951"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02650.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.1997.0110155"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis393"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200212060-00001"},{"key":"e_1_2_8_9_1","first-page":"167","article-title":"One window\u2010period donation in two years of ID\u2010NAT screening for HBV, HCV and HIV","volume":"35","author":"Levi J.E.","year":"2013","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"key":"e_1_2_8_10_1","unstructured":"Ministry of Health Brazil. (2015a) Boletim Epidemiol\u00f3gico de Aids\/DST Ano IV No 1. URLhttps:\/\/www.avert.org\/professionals\/hiv\u2010around\u2010world\/latin\u2010america\/brazil(Accessed 3\/2017);http\/\/www.saude.gov.br."},{"key":"e_1_2_8_11_1","unstructured":"Ministry of Health Brazil. (2015b) Caderno de informa\u00e7\u00e3o: sangue e hemoderivados: dados de 2014 9.154. URLhttp:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/caderno_informacao_sangue_hemoderivados_dados_201_9Accessed 3\/2017."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086413"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-60"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02851.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12180"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01506.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03344.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12316"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02110.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02622.x"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftme.12427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T19:19:09Z","timestamp":1696187949000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tme.12427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/tme.12427"],"URL":"https:\/\/doi.org\/10.1111\/tme.12427","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]},"assertion":[{"value":"2016-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}